Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 878 results for "daiichi sankyo"

DAIICHI SANKYO : Findings on Cerebral Hemorrhage Reported by Investigators at Daiichi Sankyo
4 Traders

DAIICHI SANKYO : Findings on Cerebral Hemorrhage Reported by I...

By a News Reporter-Staff News Editor at Biotech Week -- Research findings on Cardiovascular Diseases and Conditions are discussed in a new report. According to news reporting originating from Tokyo, Japan , by NewsRx correspondents, research stated, ... 4 Traders, 1 hour ago
Daiichi Sankyo appoints U.S. commercial president Chain Drug Review, 2 days ago

125 images for daiichi sankyo

4 Traders, 1 hour ago
Pharma Letter, 10 hours ago, 1 day ago, 1 day ago, 1 day ago
UPI, 2 weeks ago
Fidelity Brokerage Services LLC, 2 weeks ago
Financial Express, 2 weeks ago
NDTV, 2 weeks ago, 1 week ago


The takeover of Daiichi Sankyo owned Ranbaxy Labs by Sun Pharmaceuticals for $4 billion including a $800 million liability early this month surprised quite a few in the Indian pharmaceutical industry. There was hardly any indication of such a move ...
 PharmaBiz19 hours ago
Business Standard India

Daiichi Sankyo's moments of glory

Six years ago, when Daiichi Sankyo, the Japanese pharmaceutical giant, concluded the biggest ever foreign acquisition of an Indian manufacturing company by any group in a $4.2 billion cash deal buying the entire 34.82 per cent stake of Malvinder ...
 The Echo Of India1 week ago AFP - India-Japan-pharmaceutical-merger-Daiichi-Ranbaxy-Sun  Namibia Press Agency1 week ago Sun-rise over Modi  Business Standard1 week ago Top heads to roll soon at Ranbaxy  Business Standard India2 weeks ago
Business Standard

Is Dilip Shanghvi's big bet worth the risk?

Ranbaxy's frequent run-ins with the US FDA may have proved too much for its previous owner, Japan's Daiichi Sankyo, but for Sun Pharma, it is an astute purchase that it hopes will not only boost its position in India but also globally Reghu Balakrishnan | ...
 Business Standard2 days ago

Rising Sun

The takeover of Daiichi Sankyo-owned Ranbaxy, India’s largest pharmaceutical firm, by Sun Pharma in an all-stock deal worth nearly $4 billion is not only the largest deal in pharma in Asia but has catapulted Sun Pharma to becoming the world’s fifth ...
 Asian Age1 week ago
Money Control

DAIICHI SANKYO : Ranbaxy-sun merger deal may close by 2014-end: daiichi

04/15/2014 | 02:41am US/Eastern Recommend: Daiichi Sankyo of Japan , which holds majority stake in Ranbaxy Laboratories Ltd (RLL), has said that the $4 billion merger deal of RLL with Sun Pharma is expected to close by the end of ...
 4 Traders1 week ago Daiichi Sankyo lays out road map for Ranbaxy deal with Sun  FiercePharma1 week ago Ranbaxy-Sun Pharma merger deal may close by year-end: Daiichi  Business Line1 week ago Ranbaxy-Sun Pharma deal to close by 2014 end, says Daiichi  New Delhi Pioneer1 week ago
Business Standard India

Sun hasn't bought a lemon

, what seems to have caught everybody's attention is the massive erosion in value. Daiichi Sankyo of Japan had paid $4.2 billion for a 63.8 per cent stake in the company in 2008; once the deal is closed, it will own nine per cent in Sun Pharma, ...
 Business Standard India1 week ago Bhupesh Bhandari: Sun hasn't bought a lemon  Sify1 week ago

Update-Moody's: Daiichi Sankyo Will Benefit from Sun Pharma's Acquisition of Ranbaxy

8:00am BST Sun Pharmaceutical Industries Ltd (Sun Pharma) & Ranbaxy Laboratories Ltd (Ranbaxy) For the full text of this story please click the following
 Reuters UK2 weeks ago Daiichi Sankyo will benefit from Sun Pharma's acquisition of Ranbaxy: Moody's  Myiris2 weeks ago

LDC Forms Early Drug Discovery Alliance with Daiichi Sankyo 2014-04-19 Dortmund, Germany, April 19, 2014 --( )-- The Lead Discovery Center GmbH (LDC), a renowned translational research organization, and Daiichi Sankyo Co., Ltd. (hereafter, Daiichi Sankyo), Japan, have teamed up to discover ...
 BizWire Express4 days ago DAIICHI SANKYO : and UCSF announce collaboration in research for neurodegenerative diseases  4 Traders6 days ago Daiichi Sankyo Partners With UCSF To Develop Neurodegenerative Drugs  Bioresearch Online2 weeks ago Daiichi Sankyo and UCSF collaborate for neurodegenerative disease research  Individual.com2 weeks ago
Nikkei Asian Review

With little patience & luck, Daiichi could come good on second bet

Japanese drugmaker Daiichi Sankyo Co, which offloaded its stake in Ranbaxy to Indian generic major Sun Pharmaceutical for $2.02 billion in exchange for a 9 per cent stake in the latter and no cash, might take up to 42 months to recoup its loss from the ...
 The Financial Chronicle2 weeks ago Series of import bans, loss of credibility made Daiichi cut and run?  Economic Times2 weeks ago Daiichi Sankyo to end 6-year Ranbaxy debacle with sale  Nikkei Asian Review2 weeks ago Kyodo news summary -9-  Pharmacy Choice2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - daiichi sankyo
Get updated on latest news & your favorite topics right in your inbox!
More     Less